2nd Annual Lung Screening Summit

Science Behind Lung Cancer Screening

• Management of the Incidental Node in Chest CT, David Yankelevitz, MD
• Lung Cancer Screening in Non-Smokers and High Risk Populations, Janakiraman subramanian, MD, MPH

Finding Biomarkers and Molecular Testing

• Challenges of Tissue Acquisition and Biomarker Testing in the Community and Academic Settings, Gerard Silvestri, MD, MS
• How to Complement Biomarker Testing with Diagnostic Imaging, Edgardo S. Santos, MD

Establishing Lung Cancer Screening Programs

• How to Start a Lung Cancer Screening Program, Vicki Beckler, MBA, RN
• Community Advocacy for Lung Screening, Angela Criswell, MA
• Taking Lung Cancer Screening Program to the Next Level, William Mayfield, MD

Incidental Pulmonary Nodule Programs

• Why IPN Programs are Needed, Now More than Ever, Susan Garwood, MD
• IPN vs CT Lung Screening and How They Compare, Debby Dyer, MD

Blood Biomarkers for Early Lung Cancer Detection

• Methylation, Proteomics and Other Efforts for Early Lung Cancer Detection, Luis Raez, MD